Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-107341
Filing Date
2016-06-07
Accepted
2016-06-07 17:42:47
Documents
1
Period of Report
2016-06-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v441944_4.html 4  
1 OWNERSHIP DOCUMENT v441944_4.xml 4 22490
  Complete submission text file 0001144204-16-107341.txt   23885
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110
Business Address
GOLDBERG MORTON (Reporting) CIK: 0001619731 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 161702202